PTH and chronic kidney disease: Active vitamin D, as a drug for the routine treatment of metabolic bone disease in CKD, can inhibit PTH hypersecretion, the release of inflammatory factors, and even RAS activation to alleviate albuminuria and insulin resistance [123].